Topic: Biology

Scientists discovered that a protein called MYC helps cancer cells survive chemotherapy by repairing damaged DNA. This finding could improve treatments for some of the deadliest cancers.

Cancer is a major health concern worldwide, and scientists are working tirelessly to understand its mechanisms. Recently, researchers at Oregon Health & Science University (OHSU) made a groundbreaking discovery that could change the way we treat certain types of cancer.

The study focused on MYC, a protein that is abnormally active in most human cancers. The team found that MYC directly helps fix dangerous breaks in DNA, allowing tumor cells to recover from chemotherapy and other treatments designed to destroy them.

This finding is particularly relevant for aggressive cancers like pancreatic cancer, where MYC activity is often very high. Tumor cells in these cancers experience significant DNA damage and replication stress, yet they continue to survive and grow. The researchers suggest that MYC helps these cells cope with that stress by actively promoting DNA repair.

The study's findings may help explain why some tumors resist chemotherapy and radiation. MYC-driven cancers appear able to rapidly repair the DNA damage caused by treatment, allowing them to endure therapies that would normally destroy tumor cells.

Why It Matters

This discovery could lead to more effective treatments for pancreatic cancer and other aggressive cancers. It also highlights the importance of understanding how cancer cells adapt to different treatments.

Key Facts

• MYC is a protein abnormally active in most human cancers
• MYC helps repair damaged DNA, allowing tumor cells to survive chemotherapy
• The study focused on pancreatic cancer, one of the deadliest forms of the disease

Key Terms

MYC

A protein that is abnormally active in most human cancers

Implications

This discovery could lead to more effective treatments for pancreatic cancer and other aggressive cancers. It also highlights the importance of understanding how cancer cells adapt to different treatments.